| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.73 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms of cancer treatment, and P53 protein is one of the key molecules determining how a cell responds to radiotherapy. The aim of this study was to determine the therapeutic efficacy of iodine-131 in three human HCC cell lines.
Descrição
Palavras-chave
Carcinoma Hepatocelular ProteĆna Supressora de Tumor p53
Contexto Educativo
Citação
Clin Mol Hepatol. 2015 Sep;21(3):257-67.
